We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 6,144 results
  1. Effect of Roflumilast Cream (ARQ-151) on Itch and Itch-Related Sleep Loss in Adults with Chronic Plaque Psoriasis: Patient-Reported Itch Outcomes of a Phase 2b Trial

    Background

    Itch is the most bothersome symptom reported by patients with psoriasis. Safe and effective treatments for psoriasis that also address itch...

    Linda Stein Gold, Javier Alonso-Llamazares, ... David R. Berk in American Journal of Clinical Dermatology
    Article Open access 12 November 2022
  2. ItchyQoL reveals differences in itch symptom experience in routine dermatologic care

    Itch is a common symptom of dermatologic diseases associated with significant impairment of health-related quality of life (QoL). This study reveals...

    Syed Minhaj Rahman, Fatema Esaa, ... Julie Ryan Wolf in Archives of Dermatological Research
    Article 07 June 2024
  3. Novel Topical Treatments for Itch

    The experience of itch often poses a burden on patient quality of life and has the capacity to inflict significant suffering. Topical therapies are a...

    Rami H. Mahmoud, Omar Mahmoud, ... Gil Yosipovitch in Dermatology and Therapy
    Article Open access 13 April 2024
  4. Pathogenic mechanisms underlying itch in atopic dermatitis: the emerging role of neuroimmune interactions

    Itch is a frequent dermatological sensation that can occur in a variety of skin conditions, including atopic dermatitis, inflammatory disorders...

    Augusto Escalante, Esther Serra-Baldrich in European Journal of Dermatology
    Article 01 July 2023
  5. Itch in recessive dystrophic epidermolysis bullosa: findings of PEBLES, a prospective register study

    Background

    Itch is common and distressing in epidermolysis bullosa (EB) but has not previously been studied in depth in different recessive dystrophic...

    Jemima E. Mellerio, Elizabeth I. Pillay, ... Eunice Jeffs in Orphanet Journal of Rare Diseases
    Article Open access 09 August 2023
  6. Economic Burden of Itch-Related Sleep Loss in Moderate-to-Severe Atopic Dermatitis in the United Kingdom

    Introduction

    Atopic dermatitis is associated with intense itch, which has been shown to cause sleep disruption that significantly impacts the lives of...

    Evangeline J. Pierce, Russel T. Burge, ... Yunni Yi in Dermatology and Therapy
    Article Open access 23 April 2024
  7. Baricitinib Improvement Across Regions in Atopic Dermatitis Patients with Baseline Body Surface Area up to 40% and Severe Itch

    Introduction

    Patients with moderate-to-severe atopic dermatitis (AD) who are most likely to respond to the Janus kinase (JAK) 1/2 inhibitor...

    José-Manuel Carrascosa, Alessandra Narcisi, ... Andreas Wollenberg in Dermatology and Therapy
    Article Open access 22 May 2024
  8. Assessing Itch Severity: Content Validity and Psychometric Properties of a Patient-Reported Pruritus Numeric Rating Scale in Atopic Dermatitis

    Background

    Pruritus, or itch, is a key symptom of atopic dermatitis (AD); as such, mitigating itch is an important outcome of AD treatment. This study...

    Alissa Rams, Jessica Baldasaro, ... Evangeline Pierce in Advances in Therapy
    Article Open access 16 February 2024
  9. Mechanisms of pruritus in cholestasis: understanding and treating the itch

    Pruritus in cholestatic liver diseases can be a major burden and dramatically impair the quality of life of those affected. Here, we provide an...

    Ulrich Beuers, Frank Wolters, Ronald P. J. Oude Elferink in Nature Reviews Gastroenterology & Hepatology
    Article 28 October 2022
  10. Baseline Body Surface Area and Itch Severity Define Response to Baricitinib in Patients with Moderate-to-Severe Atopic Dermatitis at Week 16

    Introduction

    Atopic dermatitis (AD) is a chronic, inflammatory skin disease characterized by heterogeneous clinical phenotypes and high symptom...

    Jacob P. Thyssen, Marjolein de Bruin-Weller, ... Thomas Bieber in Advances in Therapy
    Article Open access 19 June 2023
  11. Rapid Improvements in Itch with Tapinarof Cream 1% Once Daily in Two Phase 3 Trials in Adults with Mild to Severe Plaque Psoriasis

    Introduction

    Patients with psoriasis report pruritus as their most bothersome symptom. Tapinarof cream 1% once daily demonstrated significant efficacy...

    Leon Kircik, Matthew Zirwas, ... Anna M. Tallman in Dermatology and Therapy
    Article Open access 21 December 2023
  12. Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2

    Background

    Abrocitinib, an oral, once-daily Janus kinase 1-selective inhibitor, improved itch severity, sleep, and work productivity versus placebo in...

    Gil Yosipovitch, Melinda J. Gooderham, ... Daniela E. Myers in American Journal of Clinical Dermatology
    Article Open access 25 August 2023
  13. Bleach baths enhance skin barrier, reduce itch but do not normalize skin dysbiosis in atopic dermatitis

    Studies have demonstrated that bleach baths improve atopic dermatitis (AD) severity; however, the effects on itch, skin barrier, and cutaneous...

    Ania Stolarczyk, Nelissa Perez-Nazario, ... Lisa A. Beck in Archives of Dermatological Research
    Article Open access 27 September 2023
  14. Role of GRPR in Acupuncture Intervention in the “Itch-scratch Vicious Cycle” Spinal Circuit of Chronic Pruritus

    Many previous studies have shown the potential antipruritic effect of acupuncture. This paper reviews the antipruritic mechanisms of acupuncture...

    Jia-jia Liu, Xuemei Li, ... Sha Yang in Chinese Medicine
    Article Open access 03 January 2023
  15. Development, Psychometric Validation and Responder Definition of Worst Itch Scale in Children with Severe Atopic Dermatitis

    Introduction

    Itch associated with atopic dermatitis (AD) has a profoundly negative effect on patients of all ages. Therefore, itch is a main target...

    Amy S. Paller, Gil Yosipovitch, ... Dimittri Delevry in Dermatology and Therapy
    Article Open access 21 October 2022
  16. Characterization of chronic itch in college students in China

    Background

    Chronic itch affects a et al. range of individuals and has a noticeable influence on human health. However, epidemiological...

    **aoyu Gu, Juan Su, ... Minxue Shen in European Journal of Dermatology
    Article 01 January 2022
  17. Cholestatic Itch: Our Current Understanding of Pathophysiology and Treatments

    Hepatic pruritus is common in liver conditions, including cholestasis and nonalcoholic fatty liver disease. The pruritus can be severe enough to...

    Ashley Vander Does, Cynthia Levy, Gil Yosipovitch in American Journal of Clinical Dermatology
    Article 28 July 2022
  18. Circ-ITCH overexpression promoted cell proliferation and migration in Hirschsprung disease through miR-146b-5p/RET axis

    Background

    Hirschsprung disease (HSCR) is a congenital intestinal disease caused by the abnormal proliferation and migration of enteric nerve cells...

    Ren-Peng **a, Fan Zhao, ... Chong-Gao Zhou in Pediatric Research
    Article 28 January 2022
  19. Early Itch Response with Abrocitinib Is Associated with Later Efficacy Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Randomized Phase III JADE COMPARE Trial

    Background

    Abrocitinib, an oral Janus kinase 1 inhibitor, provided significant itch relief by week 2 in patients with moderate-to-severe atopic...

    Sonja Ständer, Shawn G. Kwatra, ... Claire Feeney in American Journal of Clinical Dermatology
    Article Open access 13 December 2022
  20. Using botulinum toxin A to treat postherpetic itch

    Jessica Mineroff, Laura N. Uwakwe, ... Jared Jagdeo in Archives of Dermatological Research
    Article 25 September 2023
Did you find what you were looking for? Share feedback.